or Try an Advanced Search...

    Antibody Drug Conjugate Stocks List

    Symbol Grade Name % Change
    TGTX A TG Therapeutics, Inc. 7.34
    ACLX B Arcellx, Inc. 2.25
    PYXS C Pyxis Oncology, Inc. 5.62
    KPTI C Karyopharm Therapeutics Inc. -8.75
    MRSN D Mersana Therapeutics, Inc. 0.55
    ADCT F ADC Therapeutics SA 4.61
    GMAB F Genmab A/S 1.08
    CLDX F Celldex Therapeutics, Inc. -1.46
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Cancer Medicine Biotechnology Clinical Medicine Monoclonal Antibodies Solid Tumors Immunology Monoclonal Antibody Treatment Of Cancer Acute Myeloid Leukemia Clinical Development Immunotherapies Lymphoma Biopharmaceutical Camidanlumab Tesirine Cancer Treatment Cd20 Chemotherapy Drugs Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Antibody Drug Conjugate stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 5.61
    CANC C Tema Oncology ETF 5.21
    SBIO B ALPS Medical Breakthroughs ETF 4.23
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.85
    FBT A First Trust Amex Biotech Index Fund 3.31
    View all Antibody Drug Conjugate ETFs...
    Compare ETFs
    Compare CANC to FBT Compare CNCR to FBT Compare CNCR to SBIO

        Antibody Drug Conjugate Stocks Recent News

        Date Stock Title
        Nov 1 KPTI Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline
        Nov 1 ADCT Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
        Nov 1 TGTX TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
        Nov 1 ACLX Arcellx (ACLX) Surged in Q3. Here’s Why
        Oct 31 TGTX Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?
        Oct 31 KPTI Karyopharm gains after changes to late-stage trial
        Oct 31 KPTI Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
        Oct 31 KPTI Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024
        Oct 31 KPTI Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis
        Oct 31 ADCT ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
        Oct 30 KPTI Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024
        Oct 29 CLDX Celldex selloff creates buying opportunity, says Guggenheim
        Oct 29 TGTX The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts
        Oct 28 ADCT Institutional investors own a significant stake of 32% in ADC Therapeutics SA (NYSE:ADCT)
        Oct 28 CLDX Celldex Therapeutics (NASDAQ:CLDX) pulls back 6.1% this week, but still delivers shareholders fantastic 57% CAGR over 5 years
        Oct 26 CLDX Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
        Related Stock Lists: Cancer Medicine Biotechnology Clinical Medicine Monoclonal Antibodies Solid Tumors Immunology Monoclonal Antibody Treatment Of Cancer Acute Myeloid Leukemia Clinical Development Immunotherapies Lymphoma Biopharmaceutical Camidanlumab Tesirine Cancer Treatment Cd20 Chemotherapy Drugs Genetics
        Antibody Drug Conjugate

        An Antibody Drug Conjugate (ADC) is a type of targeted therapy used to treat cancer. It is a combination of an antibody, which is a protein that binds to a specific target on cancer cells, and a drug, which is a chemical that kills the cancer cells. The antibody is linked to the drug, allowing it to be delivered directly to the cancer cells. This targeted approach reduces the side effects of traditional chemotherapy, which can damage healthy cells as well as cancer cells.

        Browse All Tags